Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins
dc.authorid | Özyalın, Fatma/0000-0001-6486-6389 | |
dc.authorid | Sahin, Ibrahim/0000-0002-6231-0034 | |
dc.authorid | Taskapan, Mehmet Cagatay/0000-0002-5273-4909 | |
dc.authorid | Yologlu, Saim/0000-0002-9619-3462 | |
dc.authorid | özyalın, fatma/0000-0001-6486-6389 | |
dc.authorwosid | Özyalın, Fatma/ABC-7193-2020 | |
dc.authorwosid | Şahin, İbrahim/HHY-8303-2022 | |
dc.authorwosid | Sahin, Ibrahim/ABI-6050-2020 | |
dc.authorwosid | Taskapan, Mehmet Cagatay/ABI-7747-2020 | |
dc.authorwosid | Yologlu, Saim/ABI-8014-2020 | |
dc.authorwosid | özyalın, fatma/ABA-5258-2020 | |
dc.contributor.author | Sahin, Ibrahim | |
dc.contributor.author | Karaca, Zuhal | |
dc.contributor.author | Taskapan, Cagatay | |
dc.contributor.author | Ozyalin, Fatma | |
dc.contributor.author | Yologlu, Saim | |
dc.date.accessioned | 2024-08-04T20:56:27Z | |
dc.date.available | 2024-08-04T20:56:27Z | |
dc.date.issued | 2014 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.identifier.issn | 0163-769X | |
dc.identifier.issn | 1945-7189 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.uri | https://hdl.handle.net/11616/102300 | |
dc.identifier.volume | 35 | en_US |
dc.identifier.wos | WOS:000209805106186 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Endocrine Soc | en_US |
dc.relation.ispartof | Endocrine Reviews | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | Alteration in Bone Metabolism Markers Fallowing 3-Months Insulin Therapy in Patients with Type 2 Diabetes Mellitus: Analogues Vs. Human Insulins | en_US |
dc.type | Conference Object | en_US |